Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Hantangping is a traditional Chinese medicine (TCM) compound formulation developed for the treatment of type 2 diabetes mellitus. It is being studied as an alternative to metformin, with clinical trials designed to assess its efficacy and mechanism in glycemic control and diabetes-induced inflammatory responses. Hantangping consists of multiple herbal ingredients, characteristic of TCM compounds, but the specific composition is not detailed in available sources. Its mechanism likely involves modulation of glucose metabolism and anti-inflammatory effects, though precise molecular targets are not specified in published protocols[1][2]. The drug is under investigation primarily for early-stage type 2 diabetes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on hantangping.